Dexamethasone Therapy in VLBW Infants at Risk of CLD

Trial ID or NCT#

NCT00011362

Status

not recruiting iconNOT RECRUITING

Purpose

Infants who are on breathing support are often treated with steroids (dexamethasone); however, the best timing of therapy is not known. This trial looked at the benefits and hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in premature infants.

Official Title

Randomized Clinical Trial of Dexamethasone Therapy in Very-Low-Birth-Weight Infants at Risk for Chronic Lung Disease (CLD)

Eligibility Criteria

Ages Eligible for Study: 13 Days to 15 Days
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

David K. Stevenson, M.D.

View on ClinicalTrials.gov